Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Parvin F. Peddi, M.D.
Parvin F. Peddi, M.D.

Specialty:

Hematology/Oncology

General Information:

Gender:
Female
Language(s):
English, Farsi

Affiliation(s):

Clinical Instructor, Department of Medicine, Hematology/Oncology
Member, JCCC Signal Transduction and Therapeutics Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education:

Fellowship:
Hematology and Medical Oncology, UCLA School of Medicine, 2012 - 2013
Hematology and Medical Oncology, Washington University School of Medicine, 2010 - 2012
Residency:
Chief Resident, Internal Medicine, Washington University School of Medicine, 2009 - 2010
Internal Medicine, Washington University School of Medicine, 2007 - 2009
Internship:
Internal Medicine, Washington University School of Medicine, 2006 - 2007
Medical Degree:
M.D., Duke University School of Medicine, 2006

Certification(s):

Board Certification(s):
Medical Oncology, American Board of Internal Medicine, 2013
Internal Medicine, American Board of Internal Medicine, 2009

Contact Information:

Phone:
(310) 829 5471
Email:

Practice Information:

Clinical Interest(s):
General Oncology
General Hematology

Scientific Interest(s):

Dr. Parvin Peddi's current research focuses on breast cancer and its treatment. She has published research in various respected journals on gastrointestinal cancers, breast cancer and other malignancies.

Selected Cancer-Related Publications:

Peddi PF, Hurvitz SA. PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer. J Neurooncol. 2014 Mar;117(1):7-13. doi: 10.1007/s11060-014-1369-6. Epub 2014 Jan 28.

Rosove MH, Peddi PF, Glaspy JA. BRAF V600E inhibition in anaplastic thyroid cancer. N Engl J Med. 2013 Feb 14;368(7):684-5. doi: 10.1056/NEJMc1215697.

Peddi PF, Shatsky RA, Hurvitz SA. Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancer. Cancer Treat Rev. 2014 Mar;40(2):320-6. doi: 10.1016/j.ctrv.2013.08.004. Epub 2013 Aug 14.

Peddi PF, Lubner S, McWilliams R, Tan BR, Picus J, Sorscher SM, Suresh R, Lockhart AC, Wang J, Menias C, Gao F, Linehan D, Wang-Gillam A. Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma. JOP. 2012 Sep 10;13(5):497-501. doi: 10.6092/1590-8577/913.

Peddi PF, Ellis MJ, Ma C. Molecular basis of triple negative breast cancer and implications for therapy. Int J Breast Cancer. 2012;2012:217185. doi: 10.1155/2012/217185. Epub 2011 Nov 2.